New Technology Startups News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EAST LANSING, Mich., Jan. 26, 2022 (GLOBE NEWSWIRE) -- GreenMark Biomedical Inc. announced that the company raised $830,000 in equity financing in the...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Brighton-based FlexDex Surgical Inc. has closed on a funding round of $13 million, which was led by New Brunswick, N.J.-based Johnson & Johnson Innovation LLC, the investment arm of the pharmaceutical giant, and Almeda Ventures, an Israel firm based in Tel Aviv. The round was joined by a…

ONL Therapeutics, Inc., an Ann Arbor, Mich.-based biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, closed on $46.9m in a Series B financing round. The round included new investors Bios Partners, which led the round, Johnson & Johnson Innovation – JJDC, Inc., Kaitai Capital, PSQ Capital, and Michigan Capital Network Venture Fund III. Existing investors that participated in the round include ONL Therapeutics management, InFocus Capital Partners, ExSight Ventures, the University of Michigan’s Michigan Investment in New Technolo...

Ann Arbor eye-drug developer ONL Therapeutics raises $47 million in latest venture capital round Studies to expand into areas such as glaucoma Funding comes from mix of new and existing investors Getty Images/iStockphoto Ann Arbor-based pharmaceutical company ONL Therapeutics Inc. has closed on nearly $47 million in a Series B fundraising round that will further the company's work on developing drugs to protect against several eye conditions that cause blindness. The investment was led by Fort Worth, Texas-based venture capital firm Bios Partners, with participation from several other new inv...